OCT 11, 2018 6:47 PM PDT

New Vaccine Protects Against Lassa Fever and Rabies

WRITTEN BY: Carmen Leitch

In Africa, Lassa fever is a significant threat to public health. It is a member of the same family of viruses as Ebola. Lassa cases can be mild, but it may also cause hemorrhagic fever. The virus infects between 100,000 and 300,000 people every year, killing 5,000 of those individuals. Now researchers have created a vaccine that protects against this deadly illness, as well as rabies, another problematic virus in Africa. The vaccine has proven effective in animal models. The work has been reported in Nature Communications.

"This two-component vaccine showed good protection from exposure to both virus types in preliminary animal studies," said the senior author of the study, Matthias Schnell, Chair of the Department of Microbiology and Immunology at Jefferson (Philadelphia University + Thomas Jefferson University). Schnell is also the Director of the Jefferson Vaccine Center.

The scientists based the vaccine on one that has been used effectively for rabies over decades. It’s an inactive vaccine, so it’s likely to be safe for pregnant women, whose pregnancies are threatened by Lassa infection. 

The researchers have made their stable for storage at room temperature, so it can easily be used in the field. There is another critical benefit of this virus, Schnell explained. "Perhaps more importantly, however, we've discovered how to test for protection, which could vastly improve our ability to translate these findings into a human-ready vaccine," said Schnell.

The vaccine can’t be tested by exposing people to Lassa and then checking for efficacy, so it will have to be evaluated based on animal studies. The researchers will look for antibodies that neutralize the pathogen; the virus binds to the antibody, rendering the pathogen unable to bind to receptors on cells. Then, infection can’t occur. 

"The neutralizing antibody works like putting glue on a key," explained the first author Tiago Abreu-Mota, an MD/PhD student in Dr. Schnell's lab visiting from University of Minho, Portugal. "By junking-up the key, or entry molecule, the virus can no longer open the door to the cell."

Instead of taking the typical route to target the virus, researchers at the National Institutes of Allergy and Infectious Disease (NIAID) and University of California, San Diego (UCSD) aimed for other pieces of the pathogen - it's glycoprotein. The scientists found that in Lassa’s case, this is an effective way to flag viral particles for destruction by the immune system.

The work on this vaccine will continue as scientists seek to bring it to the clinic. Next, the vaccine will be tested in non-human primates.

Sources: Science Daily via Thomas Jefferson University, NIH, Nature Communications

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 31, 2020
Microbiology
Finding a Weakness in an Emerging Drug-Resistant Pathogen
AUG 31, 2020
Finding a Weakness in an Emerging Drug-Resistant Pathogen
Candida auris is a fungal pathogen that was initially reported in 2009. Its origins are unclear, but it has been found i ...
SEP 01, 2020
Cell & Molecular Biology
Smell Cells Are Especially Good at Fighting the Flu
SEP 01, 2020
Smell Cells Are Especially Good at Fighting the Flu
All over the body, cells line organs and vessels, forming protective barriers. But pathogens like the flu have gained th ...
SEP 10, 2020
Clinical & Molecular DX
Microscope to Diagnose River Blindness Is a Winner
SEP 10, 2020
Microscope to Diagnose River Blindness Is a Winner
  A team of innovators from Stanford University has invented the Onchoscope: a low-cost, customizable microscope fo ...
OCT 28, 2020
Microbiology
Immune Cells Link Gum Disease to Inflammatory DIsorders
OCT 28, 2020
Immune Cells Link Gum Disease to Inflammatory DIsorders
Scientists and clinicians know that oral health and inflammation, which is a part of many diseases, are connected.
NOV 15, 2020
Microbiology
Monitoring a Virus in Real-Time as it Infects a Cell
NOV 15, 2020
Monitoring a Virus in Real-Time as it Infects a Cell
Hubrecht Institute researchers observe a virus as it invades a cell and competes with the host for control of the host c ...
NOV 25, 2020
Immunology
The History of Vaccines
NOV 25, 2020
The History of Vaccines
Everyone worldwide is sitting with anticipation, waiting for the right vaccine candidate for the coronavirus outbreak, h ...
Loading Comments...